Who Are Your Dry Eye Patients? Providing Optimal Management with Cataract Surgery

Title:

Who Are Your Dry Eye Patients? Providing Optimal Management with Cataract Surgery

Topic: Ophthalmology
Relevant Terms: Dry Eye
Primary Audience: Ophthalmologists, Optometrists
Launch Date: 10-Oct-13
Credits: AMA PRA Category 1 Credit
1 COPE credit
Expiration Date: 10-Oct-14

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Describe the complications of dry eye disease (DED) in the setting of delayed diagnosis
  2. Describe recent guideline protocols for diagnosing dry eye disease (DED), classifying DED severity, and differentiating underlying etiologies of DED
  3. List the current recommendations for the treatment and follow-up of DED by level of severity and underlying etiologies

    Faculty

    Kelly Nichols, OD, MPH, PhD, FAAO (Dipl.)
    Professor
    University of Houston, College of Optometry
    Houston, Texas
    Mark T. Dunbar, OD, FAAO
    Director of Optometric Services, Optometry Residency Supervisor
    University of Miami School of Medicine 
    Bascom Palmer Eye Institute Miami
    Miami, FL
    Clark L. Springs
    Assistant Clinical Professor
    Director of Cornea and Refractive Surgery
    Glick Eye Institute
    Indiana University School of Medicine
    Indianapolis, IN
    Marc R. Bloomenstein, OD, FAAO
    Director of Optometric Services
    Schwartz Laser Eye Center
    Scottsdale, AZ
    Neda Shamie, MD
    Associate Professor of Ophthalmology
    Division of Corneal and Anterior Segment Surgery
    USC-Keck School of Medicine
    Los Angeles, CA
                                                         
    Medical Director
    Doheny Eye Institute
    Beverly Hills, CA
    Stephen C. Pflugfelder, MD
    Professor and James and Margaret Elkins Chair
    Director of the Ocular Surface Center
    Department of Ophthalmology
    Baylor College of Medicine
    Houston, TX
    Instructions on How to Receive Credit
    • Participants must review the materials on accreditation information, target audience, learning objectives, and disclosure information.
    • Complete the entire activity, pre/post-test and evaluation.
    • After passing the post-test, print out your electronic CE certificate.
    • In order to successfully complete this activity learners must achieve a minimum of 70% on the post-test.
    This activity is supported by an educational grant from the Allergan.

    This activity is sponsored by the Institute for Continuing Healthcare Education

    Release Date: October 10, 2013
    Expiration Date: October 10, 2014

     
    Accreditation Statements
    Opthalmologists
    The Institute for Continuing Healthcare Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
     
    The Institute for Continuing Healthcare Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

    Optometrists
    This course is COPE-qualified for 1.0 hour of CE credit. Please check with your state licensing board to see if this approval counts towards your actual CE requirements for relicensure. (COPE-ID #39141-SP)
     
    Disclosure
    Relationships are abbreviated as follows: E, Educational Planning Committee; G, Grant/research support recipient; A, Advisor/review panel member/educational planning committee; C, Consultant/Independent Contractor; SS, Stock shareholder; SB, Speaker bureau; PE, Promotional Event Talks; H, Honoraria; O, Other.

    Faculty
    Mark T. Dunbar, OD
    Bascom Palmer Eye Institute
    University of Miami, Miller School of Medicine
    Miami, Florida
     
    Dr. Dunbar has disclosed the following relevant financial relationships that have occured in the last 12 months: Carl Zeiss, Allergan, ArcticDx, Sucampo, Reed Exhibitions/A, PE, G, Carl Zeiss, Allergan, ArcticDx, Sucampo/SB.
     
    Mark Bloomenstein, OD
    Schwartz Laser Eye Center
    Scottsdale, Arizona
     
    Dr. Bloomenstein has disclosed the following relevant financial relationships that have occured in the last 12 months: Allergan, Bausch and Lomb, AMO, TearLab/A, Allergan, B&L, AMO/PE, Allergan/G, Odyssey, Allergan, Bausch and Lomb, TearLab, Alcon/SB.
     
    Kelly Nichols, OD, MPH, PhD, FAAO
    University of Houston, College of Optometry
    Houston, Texas
    Dr. Nichols has disclosed the following relevant financial relationships that have occured in the last 12 months: Allergan, Alcon, Bausch and Lomb/PE, Allergan, Alcon, Bausch and Lomb, Sarcode, Nicox, RPS, TearLab/C, Allergan, NIH, TearLab, Alcon/CIBA, Vistakon/G, Sarcode, TearLab/SS.
     
    Stephen C. Pfugfelder, MD
    Cullen Eye Institute
    Department of Ophthalmology
    Baylor College of Medicine
    Houston, Texas
     
    Dr. Pflugfelder has disclosed the following relevant financial relationships that have occured in the last 12 months: Allergan, GSK, Bausch and Lomb, Inc./C, Allergan, GSK/G.
     
    Neda Shamie, MD
    Doheny Eye Institute
    Beverly Hills, California
     
    Dr. Shamie has disclosed the following relevant financial relationships that have occured in the last 12 months: Bausch and Lomb, Nicox/C, Allergan, Alcon, Bausch and Lomb, Merck/SB.
     
    Clark Springs, MD
    Glick Eye Institute
    Indiana University, School of Medicine
    Indianapolis, Indiana
     
    Dr. Springs has disclosed the following relevant financial relationships that have occured in the last 12 months: Santen, Tear Science/A, R-Tech, Veno/G, Merck, Alcon/H.
     
    Medical Writer
    Tim Donald
    Donald Editorial Services, LLP
    Woodstown, NJ
     
    Mr. Donald has disclosed that he does not have any relevant financial relationships specific to the subject matter of the content of the activity.
     
    Peer Reviewer
    Mark Schaeffer, OD
    Schaeffer Eye Center
    Birmingham, Alabama
     
    Dr. Schaeffer has disclosed that he does not have any relevant financial relationships specific to the subject matter of the content of the activity.

    Activity Development and Management Team
    Cathy Pagano, CCMEPAllison A. Muller, Pharm.D, D.ABATScott Kober, MBA, CCMEPApril Reynolds, MS, ELSSandra Davidson; and Megan Small are employees of the Institute and have no relationships to disclose.
     
    Off-label Product Disclosure
    This educational activity includes discussion of published and/or investigational uses of agents that are not indicated by the U.S. Food and Drug Administration. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
     
    COURSE VIEWING REQUIREMENTS
    Supported Browsers:
    Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
    Google Chrome 18.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 13.0+ for Windows, Mac OS, or Linux
    Safari 4.0+ for Mac OSX 10.5 and above
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above

     
     
    For additional technical support, please send an email to msmall@iche.edu.
     
    General Disclosure and Copyright Statement
    The opinions expressed in this publication are those of the participating faculty and not those of the Institute for Continuing Healthcare Education (the Institute), Allergan, or any manufacturers of products mentioned herein.

    This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare professional regarding diagnostic and treatment options of a specific patient's medical condition. In no event will the Institute be responsible for any decision made or action taken based upon the information provided in this activity.

    Participants are encouraged to consult the package insert for all products for updated information and changes regarding indications, dosages, and contraindications. This recommendation is particularly important for new or infrequently used products.

    Copyright 2013. Institute for Continuing Healthcare Education (the Institute). All rights reserved. No part of this publication may be reproduced or transmitted in any other form or by any means electronic or mechanical—without first obtaining written permission from the Institute.

    The Institute reserves the right to cancel or modify the activity content, faculty, and activities if necessary.